Biochemical Characterization of a New 10% IVIG Preparation [IgG Next Generation (BT595)/Yimmugo®] Obtained from a Manufacturing Process Preserving IgA/IgM Potential of Human Plasma.

Autor: Duellberg, Christian1 (AUTHOR) christian.duellberg@biotest.com, Hannappel, Achim1 (AUTHOR), Kistner, Steffen1 (AUTHOR), Maneg, Oliver1 (AUTHOR) oliver.maneg@biotest.com
Zdroj: Drugs in R&D. Sep2023, Vol. 23 Issue 3, p245-255. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje